ArticleInvestigational new drugs2016

AZD9291 overcomes T790 M-mediated resistance through degradation of EGFR(L858R/T790M) in non-small cell lung cancer cells.

Bo Mi Ku et al.PubMed ↗Publisher ↗

No numbers read from the abstract.